Variant report

Variant	esv3436457
Chromosome Location	chr12:1917791-1921989
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:1920868-1921315	HepG2	liver:	n/a	n/a
2	ATF1	chr12:1921987-1922475	K562	blood:	n/a	n/a
3	BHLHE40	chr12:1920726-1921486	HepG2	liver:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
4	BHLHE40	chr12:1921907-1922486	K562	blood:	n/a	n/a
5	BHLHE40	chr12:1921026-1921446	K562	blood:	n/a	chr12:1921279-1921288 chr12:1921277-1921290 chr12:1921273-1921294 chr12:1921280-1921289 chr12:1921279-1921288
6	BHLHE40	chr12:1919741-1919978	K562	blood:	n/a	n/a
7	BHLHE40	chr12:1919012-1919508	K562	blood:	n/a	n/a
8	CTCF	chr12:1919988-1920012	GM19239	blood:	n/a	n/a
9	CTCF	chr12:1919961-1920006	NHEK	skin:	n/a	n/a
10	CUX1	chr12:1919339-1919506	K562	blood:	n/a	n/a
11	ELF1	chr12:1920758-1921139	HepG2	liver:	n/a	n/a
12	ELF1	chr12:1920818-1921125	HepG2	liver:	n/a	n/a
13	EP300	chr12:1920800-1921211	HepG2	liver:	n/a	n/a
14	EP300	chr12:1920969-1920974	HepG2	liver:	n/a	n/a
15	EP300	chr12:1920794-1921249	HepG2	liver:	n/a	n/a
16	EP300	chr12:1919125-1919478	K562	blood:	n/a	chr12:1919275-1919285
17	EP300	chr12:1921857-1922359	HepG2	liver:	n/a	n/a
18	EP300	chr12:1920971-1921022	K562	blood:	n/a	n/a
19	EP300	chr12:1921987-1922509	HepG2	liver:	n/a	n/a
20	FOS	chr12:1919406-1919501	MCF10A-Er-Src	breast:	n/a	n/a
21	FOS	chr12:1921962-1922445	MCF10A-Er-Src	breast:	n/a	chr12:1922276-1922287
22	FOS	chr12:1919426-1919518	MCF10A-Er-Src	breast:	n/a	n/a
23	FOS	chr12:1920847-1921211	HUVEC	blood vessel:	n/a	chr12:1921013-1921024
24	FOSL1	chr12:1919286-1919632	K562	blood:	n/a	n/a
25	FOSL2	chr12:1921859-1922531	HepG2	liver:	n/a	chr12:1921946-1921957
26	FOSL2	chr12:1920673-1921412	HepG2	liver:	n/a	chr12:1920785-1920793
27	FOSL2	chr12:1919238-1919586	HepG2	liver:	n/a	n/a
28	FOSL2	chr12:1921934-1922528	HepG2	liver:	n/a	chr12:1921946-1921957
29	FOSL2	chr12:1920715-1921279	HepG2	liver:	n/a	chr12:1920785-1920793
30	FOXA1	chr12:1921988-1922443	HepG2	liver:	n/a	n/a
31	FOXA2	chr12:1919190-1919367	HepG2	liver:	n/a	n/a
32	GABPA	chr12:1920894-1921092	HepG2	liver:	n/a	n/a
33	GABPA	chr12:1921731-1922552	HL-60	blood:	n/a	n/a
34	HCFC1	chr12:1921952-1922323	K562	blood:	n/a	n/a
35	HDAC2	chr12:1921916-1922435	HepG2	liver:	n/a	n/a
36	HDAC2	chr12:1920767-1921337	HepG2	liver:	n/a	n/a
37	HEY1	chr12:1919353-1919716	HepG2	liver:	n/a	n/a
38	HEY1	chr12:1920604-1921363	HepG2	liver:	n/a	chr12:1920651-1920666
39	HEY1	chr12:1921841-1922377	HepG2	liver:	n/a	n/a
40	HNF4A	chr12:1920785-1921249	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
41	HNF4A	chr12:1920376-1921345	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
42	HNF4A	chr12:1920411-1921160	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921022-1921037 chr12:1921024-1921036
43	HNF4G	chr12:1920819-1921167	HepG2	liver:	n/a	chr12:1921024-1921036 chr12:1921019-1921041 chr12:1921023-1921038 chr12:1921024-1921037 chr12:1921021-1921036 chr12:1921024-1921036
44	HNF4G	chr12:1921889-1922464	HepG2	liver:	n/a	chr12:1922203-1922216 chr12:1922204-1922216 chr12:1922204-1922217 chr12:1922201-1922219 chr12:1922203-1922218 chr12:1922203-1922218 chr12:1922203-1922217 chr12:1922204-1922216 chr12:1922205-1922217 chr12:1922199-1922221 chr12:1922210-1922223 chr12:1922203-1922216 chr12:1922203-1922216 chr12:1922204-1922216 chr12:1922210-1922223 chr12:1922203-1922217 chr12:1922203-1922218 chr12:1922206-1922228 chr12:1922204-1922216 chr12:1922201-1922213 chr12:1922201-1922216
45	JUN	chr12:1920951-1921082	HepG2	liver:	n/a	n/a
46	JUN	chr12:1919292-1919635	K562	blood:	n/a	n/a
47	JUN	chr12:1918796-1919929	K562	blood:	n/a	n/a
48	JUN	chr12:1921789-1923042	K562	blood:	n/a	chr12:1921946-1921957
49	JUND	chr12:1920810-1921139	HepG2	liver:	n/a	chr12:1921013-1921024
50	JUND	chr12:1920812-1921151	HepG2	liver:	n/a	chr12:1921013-1921024

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:1921115-1921165	MCF10A-Er-Src	breast:	n/a
2	chr12:1921115-1921165	Jurkat	blood:	n/a
3	chr12:1921115-1921165	NHDF-neo	bronchial:	n/a
4	chr12:1921115-1921165	SKMC	muscle:	n/a
5	chr12:1921115-1921165	NT2-D1	testis:	n/a
6	chr12:1921115-1921165	HEK293	kidney:	embryo
7	chr12:1921115-1921165	AG10803	skin:	n/a
8	chr12:1921115-1921165	ovcar-3	ovarian:	n/a
9	chr12:1921115-1921165	GM12892	blood:	n/a
10	chr12:1921115-1921165	CMK	blood:	n/a
11	chr12:1921115-1921165	HNPCEpiC	eye:	n/a
12	chr12:1921115-1921165	RPTEC	kidney:	n/a
13	chr12:1921115-1921165	SK-N-SH	brain:	n/a
14	chr12:1921115-1921165	U87	brain:	n/a
15	chr12:1921115-1921165	HRE	kidney:	n/a
16	chr12:1921115-1921165	HL-60	blood:	n/a
17	chr12:1921115-1921165	AoSMC	blood vessel:	n/a
18	chr12:1921115-1921165	K562	blood:	n/a
19	chr12:1921115-1921165	IMR90	lung:	fetal
20	chr12:1921115-1921165	AG04450	lung:	fetal
21	chr12:1921115-1921165	SK-N-SH_RA	brain:	n/a
22	chr12:1921115-1921165	GM12891	blood:	n/a
23	chr12:1921115-1921165	PFSK-1	brain:	n/a
24	chr12:1921115-1921165	HCM	heart:	n/a
25	chr12:1921115-1921165	AG09309	skin:	n/a
26	chr12:1921115-1921165	H1-hESC	embryonic stem cell:	embryo
27	chr12:1921115-1921165	AG09319	gingival:	n/a
28	chr12:1921115-1921165	BJ	skin:	n/a
29	chr12:1921115-1921165	LNCaP	prostate:	n/a
30	chr12:1921115-1921165	HRCEpiC	kidney:	n/a
31	chr12:1921115-1921165	ProgFib	skin:	n/a
32	chr12:1921115-1921165	A549	lung:	n/a
33	chr12:1921115-1921165	HIPEpiC	eye:	n/a
34	chr12:1921115-1921165	HAEpiC	amniotic membrane:	n/a
35	chr12:1921115-1921165	NHBE	bronchial:	n/a
36	chr12:1921115-1921165	MCF-7	breast:	n/a
37	chr12:1921115-1921165	SK-N-MC	brain:	n/a
38	chr12:1921115-1921165	HCPEpiC	choroid plexus:	n/a
39	chr12:1921115-1921165	AG04449	skin:	fetal
40	chr12:1921115-1921165	HCT-116	colon:	n/a
41	chr12:1921115-1921165	HEEpiC	esophagus:	n/a
42	chr12:1921115-1921165	HUVEC	blood vessel:	n/a
43	chr12:1921115-1921165	HepG2	liver:	n/a
44	chr12:1921115-1921165	GM06990	blood:	n/a
45	chr12:1921115-1921165	Hepatocyte	liver:	n/a
46	chr12:1921115-1921165	GM19239	blood:	n/a
47	chr12:1921115-1921165	Caco-2	colon:	n/a
48	chr12:1921115-1921165	NH-A	brain:	n/a
49	chr12:1921115-1921165	HRPEpiC	eye:	n/a
50	chr12:1921115-1921165	T-47D	breast:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:1915615..1917986-chr12:1924786..1926838,2	K562	blood:
2	chr12:1904001..1906826-chr12:1919472..1921344,2	K562	blood:
3	chr11:62647795..62648738-chr12:1919373..1920206,2	NB4	blood:
4	chr12:1912567..1914410-chr12:1917472..1919007,2	K562	blood:
5	chr12:1921269..1923557-chr12:2112437..2115050,2	MCF-7	breast:
6	chr12:1918012..1920353-chr12:1939627..1941633,2	MCF-7	breast:
7	chr12:1690585..1692934-chr12:1917638..1919676,2	K562	blood:

Variant related genes	Relation type
CACNA2D4	TF binding region
CACNA2D4	CpG island
ENSG00000151065	chromatin interactions
ENSG00000151062	chromatin interactions
ENSG00000203593	chromatin interactions
ENSG00000168003	chromatin interactions

Extended variants
information (count: 216 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:216 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs533012574	chr12:1917802-1917803	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs545047704	chr12:1917812-1917813	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs183528048	chr12:1917848-1917849	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs149670583	chr12:1917860-1917861	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs547008594	chr12:1917861-1917862	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs568732486	chr12:1917870-1917871	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs115118384	chr12:1917871-1917872	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs79248306	chr12:1917875-1917876	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs186707847	chr12:1917887-1917888	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs539518073	chr12:1917894-1917895	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs557745287	chr12:1917925-1917926	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs145490818	chr12:1917928-1917929	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs534175212	chr12:1917951-1917952	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs78510488	chr12:1917952-1917953	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs148851152	chr12:1917991-1917992	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs557167628	chr12:1918030-1918031	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs556296472	chr12:1918031-1918032	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs577831039	chr12:1918067-1918068	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs144066371	chr12:1918073-1918074	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs560269888	chr12:1918155-1918156	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs572120512	chr12:1918164-1918165	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs569958341	chr12:1918229-1918230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs74980847	chr12:1918234-1918235	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs562251645	chr12:1918239-1918240	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs74431964	chr12:1918273-1918274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs146482202	chr12:1918307-1918308	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs562707214	chr12:1918330-1918331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs141039632	chr12:1918333-1918334	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs572284986	chr12:1918348-1918349	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs150911094	chr12:1918360-1918361	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs561306563	chr12:1918368-1918369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs528492118	chr12:1918379-1918380	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs144855217	chr12:1918380-1918381	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs114077763	chr12:1918386-1918387	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs533951412	chr12:1918422-1918423	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs540488969	chr12:1918481-1918482	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs112390921	chr12:1918523-1918524	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs77779352	chr12:1918547-1918548	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs370726441	chr12:1918562-1918563	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs146761598	chr12:1918574-1918575	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs373491312	chr12:1918644-1918645	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs73593713	chr12:1918658-1918659	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs553948263	chr12:1918670-1918671	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs79554674	chr12:1918688-1918689	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs542257864	chr12:1918732-1918733	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs76919112	chr12:1918740-1918741	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs574266880	chr12:1918771-1918772	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs192411683	chr12:1918841-1918842	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs140426573	chr12:1918847-1918848	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs533393559	chr12:1918854-1918855	Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Cancer	20164919	CNVD
Urothelial carcinoma	21177765	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:169 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:1905600-1928600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr12:1910800-1920000	Weak transcription	Primary B cells from cord blood	blood
3	chr12:1911600-1919200	Weak transcription	Osteobl	bone
4	chr12:1913800-1918800	Enhancers	Monocytes-CD14+_RO01746	blood
5	chr12:1913800-1920000	Enhancers	Fetal Thymus	thymus
6	chr12:1913800-1920400	Enhancers	Primary monocytes fromperipheralblood	blood
7	chr12:1914000-1920400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr12:1914200-1918400	Weak transcription	Primary T helper cells fromperipheralblood	blood
9	chr12:1914200-1918600	Weak transcription	K562	blood
10	chr12:1914200-1919600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
11	chr12:1914200-1919800	Weak transcription	Primary T cells from cord blood	blood
12	chr12:1914200-1920000	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
13	chr12:1914200-1920600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
14	chr12:1914400-1918800	Weak transcription	Brain Germinal Matrix	brain
15	chr12:1914400-1919800	Weak transcription	Primary neutrophils fromperipheralblood	blood
16	chr12:1914400-1919800	Weak transcription	Primary T helper cells PMA-I stimulated	--
17	chr12:1914400-1920400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr12:1914600-1917800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
19	chr12:1915200-1917800	Weak transcription	Spleen	Spleen
20	chr12:1915200-1919600	Weak transcription	Lung	lung
21	chr12:1915600-1917800	Enhancers	Fetal Brain Male	brain
22	chr12:1915600-1920600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
23	chr12:1916000-1919200	Weak transcription	Adipose Nuclei	Adipose
24	chr12:1916000-1919800	Weak transcription	NHDF-Ad	bronchial
25	chr12:1916000-1921200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
26	chr12:1916000-1921600	Weak transcription	HSMM	muscle
27	chr12:1916200-1918000	Weak transcription	Skeletal Muscle Male	skeletal muscle
28	chr12:1916200-1918200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
29	chr12:1916200-1918400	Weak transcription	Left Ventricle	heart
30	chr12:1916600-1918800	Enhancers	HepG2	liver
31	chr12:1916800-1919000	Weak transcription	Fetal Muscle Leg	muscle
32	chr12:1917000-1917800	Weak transcription	Skeletal Muscle Female	skeletal muscle
33	chr12:1917000-1919600	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr12:1917000-1919600	Weak transcription	Right Ventricle	heart
35	chr12:1917000-1919800	Weak transcription	Duodenum Mucosa	Duodenum
36	chr12:1917000-1920600	Weak transcription	Fetal Intestine Large	intestine
37	chr12:1917000-1923000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
38	chr12:1917400-1918000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
39	chr12:1917600-1918000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
40	chr12:1917600-1918800	Weak transcription	Placenta	Placenta
41	chr12:1917600-1920200	Enhancers	Primary T cells fromperipheralblood	blood
42	chr12:1917600-1920800	Weak transcription	Fetal Intestine Small	intestine
43	chr12:1917800-1918800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
44	chr12:1917800-1919600	Enhancers	Spleen	Spleen
45	chr12:1917800-1921400	Enhancers	Skeletal Muscle Female	skeletal muscle
46	chr12:1918000-1918400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr12:1918000-1918400	Enhancers	Skeletal Muscle Male	skeletal muscle
48	chr12:1918000-1921200	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
49	chr12:1918200-1918400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
50	chr12:1918200-1918400	Enhancers	Thymus	Thymus

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links